Ardelyx, Inc. (ARDX)
3.795
+0.04
(+0.93%)
USD |
NASDAQ |
Sep 02, 16:00
3.79
0.00 (0.00%)
After-Hours: 17:53
Ardelyx Cash and Short Term Investments (Quarterly) : 281.83M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 281.83M |
| March 31, 2026 | 238.07M |
| December 31, 2025 | 264.69M |
| September 30, 2025 | 242.70M |
| June 30, 2025 | 238.45M |
| March 31, 2025 | 213.95M |
| December 31, 2024 | 250.10M |
| September 30, 2024 | 190.40M |
| June 30, 2024 | 185.96M |
| March 31, 2024 | 202.58M |
| December 31, 2023 | 184.30M |
| September 30, 2023 | 165.08M |
| June 30, 2023 | 127.58M |
| March 31, 2023 | 130.37M |
| December 31, 2022 | 123.91M |
| September 30, 2022 | 90.62M |
| June 30, 2022 | 81.01M |
| March 31, 2022 | 89.70M |
| December 31, 2021 | 116.69M |
| September 30, 2021 | 141.65M |
| June 30, 2021 | 171.81M |
| March 31, 2021 | 178.21M |
| December 31, 2020 | 186.48M |
| September 30, 2020 | 185.50M |
| June 30, 2020 | 204.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 223.21M |
| December 31, 2019 | 247.51M |
| September 30, 2019 | 103.54M |
| June 30, 2019 | 123.94M |
| March 31, 2019 | 151.56M |
| December 31, 2018 | 168.09M |
| September 30, 2018 | 186.41M |
| June 30, 2018 | 212.73M |
| March 31, 2018 | 127.45M |
| December 31, 2017 | 133.98M |
| September 30, 2017 | 129.29M |
| June 30, 2017 | 148.72M |
| March 31, 2017 | 173.42M |
| December 31, 2016 | 200.82M |
| September 30, 2016 | 230.09M |
| June 30, 2016 | 146.67M |
| March 31, 2016 | 171.68M |
| December 31, 2015 | 107.00M |
| September 30, 2015 | 129.05M |
| June 30, 2015 | 141.53M |
| March 31, 2015 | 98.32M |
| December 31, 2014 | 107.29M |
| September 30, 2014 | 112.04M |
| June 30, 2014 | 117.81M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| REGENXBIO, Inc. | 105.74M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |